Biological
Inactivated Hepatitis A vaccine
Inactivated Hepatitis A vaccine is a biological therapy with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)
Phase Distribution
Ph phase_3
3
60%
Ph phase_4
2
40%
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Phase Distribution5 total trials
Phase 3Large-scale testing
3(60.0%)
Phase 4Post-market surveillance
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 33 (60.0%)
Phase 42 (40.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_3
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)
NCT03654677
completedphase_3
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine
NCT03654664
completedphase_4
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine
NCT04953325
completedphase_3
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine
NCT01453348
completedphase_4
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX
NCT02526550
Clinical Trials (5)
Showing 5 of 5 trials
NCT03654677Phase 3
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A)
NCT03654664Phase 3
To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine
NCT04953325Phase 4
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine
NCT01453348Phase 3
Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine
NCT02526550Phase 4
Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5